AU1390299A - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding themInfo
- Publication number
- AU1390299A AU1390299A AU13902/99A AU1390299A AU1390299A AU 1390299 A AU1390299 A AU 1390299A AU 13902/99 A AU13902/99 A AU 13902/99A AU 1390299 A AU1390299 A AU 1390299A AU 1390299 A AU1390299 A AU 1390299A
- Authority
- AU
- Australia
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- secreted
- proteins
- polynucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96578997A | 1997-11-07 | 1997-11-07 | |
US08965789 | 1997-11-07 | ||
US18593698A | 1998-11-04 | 1998-11-04 | |
US09185936 | 1998-11-04 | ||
PCT/US1998/023829 WO1999024469A1 (en) | 1997-11-07 | 1998-11-06 | Secreted proteins and polynucleotides encoding them |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1390299A true AU1390299A (en) | 1999-05-31 |
Family
ID=26881606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13902/99A Abandoned AU1390299A (en) | 1997-11-07 | 1998-11-06 | Secreted proteins and polynucleotides encoding them |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1028974A1 (en) |
JP (1) | JP2003525567A (en) |
AU (1) | AU1390299A (en) |
CA (1) | CA2309007A1 (en) |
WO (1) | WO1999024469A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036685A2 (en) * | 1999-11-17 | 2001-05-25 | Nyxis Neurotherapies, Inc. | Differential gene expression in cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
UA71889C2 (en) * | 1996-04-02 | 2005-01-17 | Йєда Рісерч Енд Дівелопмент Ко. Лтд. | Modulators of tnf factor (traf) related to receptor, preparation and use thereof |
-
1998
- 1998-11-06 AU AU13902/99A patent/AU1390299A/en not_active Abandoned
- 1998-11-06 WO PCT/US1998/023829 patent/WO1999024469A1/en not_active Application Discontinuation
- 1998-11-06 JP JP2000520477A patent/JP2003525567A/en not_active Withdrawn
- 1998-11-06 EP EP98957713A patent/EP1028974A1/en not_active Withdrawn
- 1998-11-06 CA CA002309007A patent/CA2309007A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999024469A1 (en) | 1999-05-20 |
JP2003525567A (en) | 2003-09-02 |
EP1028974A1 (en) | 2000-08-23 |
CA2309007A1 (en) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3381797A (en) | Secreted proteins and polynucleotides encoding them | |
AU6050898A (en) | Secreted proteins and polynucleotides encoding them | |
AU6578398A (en) | Secreted proteins and polynucleotides encoding them | |
AU6777298A (en) | Secreted proteins and polynucleotides encoding them | |
AU3890797A (en) | Secreted proteins and polynucleotides encoding them | |
AU7159898A (en) | Secreted proteins and polynucleotides encoding them | |
AU7807298A (en) | Secreted proteins and polynucleotides encoding them | |
AU6702298A (en) | Secreted proteins and polynucleotides encoding them | |
AU1101199A (en) | Secreted proteins and polynucleotides encoding them | |
AU3810097A (en) | Secreted proteins and polynucleotides encoding them | |
AU7142498A (en) | Secreted proteins and polynucleotides encoding them | |
AU1417899A (en) | Secreted proteins and polynucleotides encoding them | |
AU6337398A (en) | Secreted proteins and polynucleotides encoding them | |
AU5828398A (en) | Secreted proteins and polynucleotides encoding them | |
AU6590898A (en) | Secreted proteins and polynucleotides encoding them | |
AU2459397A (en) | Secreted proteins and polynucleotides encoding them | |
AU8824098A (en) | Secreted proteins and polynucleotides encoding them | |
AU5801998A (en) | Secreted proteins and polynucleotides encoding them | |
AU6546898A (en) | Secreted proteins and polynucleotides encoding them | |
AU7826498A (en) | Secreted proteins and polynucleotides encoding them | |
AU2728697A (en) | Secreted proteins and polynucleotides encoding them | |
AU6765098A (en) | Secreted proteins and polynucleotides encoding them | |
AU1536399A (en) | Secreted proteins and polynucleotides encoding them | |
AU5822398A (en) | Secreted proteins and polynucleotides encoding them | |
AU9600398A (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |